tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Financial Statements

Compare
159 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently $1.82M. The company's EPS TTM is $-268.078; its P/E ratio is ―; Revelation Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-10.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -25.05K$ -40.01K$ -69.17K$ 0.00$ 0.00
Operating Income$ -8.66M$ -10.86M$ -11.95M$ -145.49K$ -3.64K
EBITDA$ -95.21K$ -10.84M$ -11.93M$ -145.49K$ -3.64K
Net Income$ -120.25K$ -10.79M$ -11.99M$ -1.63M$ -3.64K
Balance Sheet
Cash & Short-Term Investments$ 11.99M$ 5.25M$ 1.27M$ 4.49M$ 0.00
Total Assets$ 12.21M$ 5.50M$ 2.04M$ 4.62M$ 22.67K
Total Debt$ 0.00$ 0.00$ 16.75K$ 0.00$ 0.00
Net Debt$ -11.99M$ -5.25M$ -1.26M$ -4.49M$ 0.00
Total Liabilities$ 5.56M$ 4.45M$ 2.14M$ 1.21M$ 26.31K
Stockholders' Equity$ 6.65M$ 1.05M$ -99.47K$ 3.41M$ -3.64K
Cash Flow
Free Cash Flow$ -7.29M$ -11.22M$ -11.22M$ -215.07K$ 0.00
Operating Cash Flow$ -7.29M$ -11.22M$ -11.09M$ -215.07K$ 0.00
Investing Cash Flow$ 0.00$ 0.00$ -131.96K$ -74.04M$ 0.00
Financing Cash Flow$ 14.03M$ 15.20M$ 8.00M$ 74.26M$ 0.00
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis